6.990CAD+3.25%Mkt Cap: 1.90B $P/E: —1d ago
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The comp…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
1M Perf
Higher
Indicators:|
Key Statistics
Company
Market Cap1.90B $
Enterprise Value16.78B $
Revenue (TTM)7.67B $
Gross Profit5.28B $
Net Income (TTM)114.34M $
Revenue/Share20.63 USD
Last Price6.990 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees20.3K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA0717341071
Valuation
P/E (Trailing)—
P/E (Forward)1.17
PEG0.02
EV/EBITDA6.38
EV/Revenue2.19
P/S0.25
P/B-0.89
EPS (TTM)-4.60
EPS (Forward)5.99
52W Range
6.45010% of range11.97
52W High11.97 CAD
52W Low6.450 CAD
Profitability
Gross Margin70.65%
Oper. Margin20.64%
EBITDA Margin34.32%
Profit Margin1.53%
ROE-28.34%
ROA0.60%
Growth
Revenue Growth11.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.02B $
CapEx (TTM)296.40M $
FCF Margin10.67%
FCF Yield43.04%
Net Debt14.20B $
Net Debt/EBITDA5.39
Balance Sheet
Debt/Equity-37.64
Current Ratio1.32
Quick Ratio0.77
Book Value/Sh-7.8235 CAD
Cash/Share3.478 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield6.46%
Payout Ratio0.00%
Ex-Div DateNov 10, 2010
Pay Date—
Splits
Last Split2:1
Split DateOct 5, 2000
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.373.48M
Float259.97M
Insiders11.13%
Institutions65.08%
Short Interest
Short Ratio7.4d
Short % Float1.20%
Short % Out.0.96%
Shares Short3.57M
Short (prev mo.)3.09M
Technical
SMA 507.360 (-5.0%)
SMA 2008.354 (-16.3%)
Beta0.41
S&P 52W Chg20.05%
Avg Vol (30d)555.40K
Avg Vol (10d)708.01K
Technical Indicators
RSI (14)47.8
MACD-0.1170
MACD Signal-0.1450
MACD Hist.+0.0280
BB Upper7.539 CAD
BB Middle7.013 CAD
BB Lower6.486 CAD
BB Width15.00%
ATR (14)0.3968 CAD
Vol Ratio (20d)0.88x